Additional clinical benefit is the key value message of manufacturers. Payers often have a different definition and perception of clinical value. In addition payers are gaining influence on both decision makers and providers. This may lead to a delay of market access and market uptake.
Access to and communication with payers is crucial. However, there are barriers!
pharmaLevers is helping clients to overcome these barriers by:
facilitating access to payers
delivering payer insights
delivering messages that are addressing payers key concerns directly
design and implement new ways to marketing drugs to payers